187 related articles for article (PubMed ID: 9092480)
1. Differential regulation of HIV-1 fusion cofactor expression by CD28 costimulation of CD4+ T cells.
Carroll RG; Riley JL; Levine BL; Feng Y; Kaushal S; Ritchey DW; Bernstein W; Weislow OS; Brown CR; Berger EA; June CH; St Louis DC
Science; 1997 Apr; 276(5310):273-6. PubMed ID: 9092480
[TBL] [Abstract][Full Text] [Related]
2. Antiviral effect and ex vivo CD4+ T cell proliferation in HIV-positive patients as a result of CD28 costimulation.
Levine BL; Mosca JD; Riley JL; Carroll RG; Vahey MT; Jagodzinski LL; Wagner KF; Mayers DL; Burke DS; Weislow OS; St Louis DC; June CH
Science; 1996 Jun; 272(5270):1939-43. PubMed ID: 8658167
[TBL] [Abstract][Full Text] [Related]
3. Engagement of CD28 modulates CXC chemokine receptor 4 surface expression in both resting and CD3-stimulated CD4+ T cells.
Secchiero P; Zella D; Curreli S; Mirandola P; Capitani S; Gallo RC; Zauli G
J Immunol; 2000 Apr; 164(8):4018-24. PubMed ID: 10754293
[TBL] [Abstract][Full Text] [Related]
4. The mode and duration of anti-CD28 costimulation determine resistance to infection by macrophage-tropic strains of human immunodeficiency virus type 1 in vitro.
Creson JR; Lin AA; Li Q; Broad DF; Roberts MR; Anderson SJ
J Virol; 1999 Nov; 73(11):9337-47. PubMed ID: 10516042
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of CD3/CD28-mediated activation of the MEK/ERK signaling pathway represses replication of X4 but not R5 human immunodeficiency virus type 1 in peripheral blood CD4(+) T lymphocytes.
Popik W; Pitha PM
J Virol; 2000 Mar; 74(6):2558-66. PubMed ID: 10684270
[TBL] [Abstract][Full Text] [Related]
6. Toll-Like Receptor 2 Ligation Enhances HIV-1 Replication in Activated CCR6+ CD4+ T Cells by Increasing Virus Entry and Establishing a More Permissive Environment to Infection.
Bolduc JF; Ouellet M; Hany L; Tremblay MJ
J Virol; 2017 Feb; 91(4):. PubMed ID: 27928019
[TBL] [Abstract][Full Text] [Related]
7. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes.
Bleul CC; Wu L; Hoxie JA; Springer TA; Mackay CR
Proc Natl Acad Sci U S A; 1997 Mar; 94(5):1925-30. PubMed ID: 9050881
[TBL] [Abstract][Full Text] [Related]
8. Optimization of ex vivo activation and expansion of macaque primary CD4-enriched peripheral blood mononuclear cells for use in anti-HIV immunotherapy and gene therapy strategies.
Zhang D; Murakami A; Johnson RP; Sui J; Cheng J; Bai J; Marasco WA
J Acquir Immune Defic Syndr; 2003 Mar; 32(3):245-54. PubMed ID: 12626883
[TBL] [Abstract][Full Text] [Related]
9. Identification of an unique CXCR4 epitope whose ligation inhibits infection by both CXCR4 and CCR5 tropic human immunodeficiency type-I viruses.
Adachi T; Tanaka R; Kodama A; Saito M; Takahashi Y; Ansari AA; Tanaka Y
Retrovirology; 2011 Oct; 8():84. PubMed ID: 22018245
[TBL] [Abstract][Full Text] [Related]
10. A novel role for tumor necrosis factor-alpha in regulating susceptibility of activated CD4+ T cells from human and nonhuman primates for distinct coreceptor using lentiviruses.
Brice GT; Mayne AE; Villinger F; Ansari AA
J Acquir Immune Defic Syndr; 2000 May; 24(1):10-22. PubMed ID: 10877490
[TBL] [Abstract][Full Text] [Related]
11. Role of CCR5 in infection of primary macrophages and lymphocytes by macrophage-tropic strains of human immunodeficiency virus: resistance to patient-derived and prototype isolates resulting from the delta ccr5 mutation.
Rana S; Besson G; Cook DG; Rucker J; Smyth RJ; Yi Y; Turner JD; Guo HH; Du JG; Peiper SC; Lavi E; Samson M; Libert F; Liesnard C; Vassart G; Doms RW; Parmentier M; Collman RG
J Virol; 1997 Apr; 71(4):3219-27. PubMed ID: 9060685
[TBL] [Abstract][Full Text] [Related]
12. Low T-cell responses to CD3 plus CD28 monoclonal antibodies are predictive of development of AIDS.
Roos MT; Prins M; Koot M; de Wolf F; Bakker M; Coutinho RA; Miedema F; Schellekens PT
AIDS; 1998 Oct; 12(14):1745-51. PubMed ID: 9792374
[TBL] [Abstract][Full Text] [Related]
13. Naïve and memory CD4 T cells differ in their susceptibilities to human immunodeficiency virus type 1 infection following CD28 costimulation: implicatip6s for transmission and pathogenesis.
Riley JL; Levine BL; Craighead N; Francomano T; Kim D; Carroll RG; June CH
J Virol; 1998 Oct; 72(10):8273-80. PubMed ID: 9733871
[TBL] [Abstract][Full Text] [Related]
14. Naive CD4 T cells inhibit CD28-costimulated R5 HIV replication in memory CD4 T cells.
Mengozzi M; Malipatlolla M; De Rosa SC; Herzenberg LA; Herzenberg LA; Roederer M
Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11644-9. PubMed ID: 11562498
[TBL] [Abstract][Full Text] [Related]
15. Identification of a major co-receptor for primary isolates of HIV-1.
Deng H; Liu R; Ellmeier W; Choe S; Unutmaz D; Burkhart M; Di Marzio P; Marmon S; Sutton RE; Hill CM; Davis CB; Peiper SC; Schall TJ; Littman DR; Landau NR
Nature; 1996 Jun; 381(6584):661-6. PubMed ID: 8649511
[TBL] [Abstract][Full Text] [Related]
16. CD32 expression is associated to T-cell activation and is not a marker of the HIV-1 reservoir.
Badia R; Ballana E; Castellví M; García-Vidal E; Pujantell M; Clotet B; Prado JG; Puig J; Martínez MA; Riveira-Muñoz E; Esté JA
Nat Commun; 2018 Jul; 9(1):2739. PubMed ID: 30013105
[TBL] [Abstract][Full Text] [Related]
17. Human immunodeficiency virus type 1 infection of CD4+ T cells down-regulates the expression of CD28: effect on T cell activation and cytokine production.
Haffar OK; Smithgall MD; Wong JG; Bradshaw J; Linsley PS
Clin Immunol Immunopathol; 1995 Dec; 77(3):262-70. PubMed ID: 7586736
[TBL] [Abstract][Full Text] [Related]
18. Costimulation of T-cell activation and virus production by B7 antigen on activated CD4+ T cells from human immunodeficiency virus type 1-infected donors.
Haffar OK; Smithgall MD; Bradshaw J; Brady B; Damle NK; Linsley PS
Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11094-8. PubMed ID: 7504294
[TBL] [Abstract][Full Text] [Related]
19. Antigen-driven C-C chemokine-mediated HIV-1 suppression by CD4(+) T cells from exposed uninfected individuals expressing the wild-type CCR-5 allele.
Furci L; Scarlatti G; Burastero S; Tambussi G; Colognesi C; Quillent C; Longhi R; Loverro P; Borgonovo B; Gaffi D; Carrow E; Malnati M; Lusso P; Siccardi AG; Lazzarin A; Beretta A
J Exp Med; 1997 Aug; 186(3):455-60. PubMed ID: 9236198
[TBL] [Abstract][Full Text] [Related]
20. Immune hyperactivation of HIV-1-infected T cells mediated by Tat and the CD28 pathway.
Ott M; Emiliani S; Van Lint C; Herbein G; Lovett J; Chirmule N; McCloskey T; Pahwa S; Verdin E
Science; 1997 Mar; 275(5305):1481-5. PubMed ID: 9045614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
